glutathione transferase p1 1 S-transferase using spectrophotometric determination of 1 Phosphorylation of Glutathione S-Transferase P1

(SEE BELOW FOR UPDATE) Results from the second round are even more compelling Round 2 (2024) Duration: 12 weeks Participants: eleven firefighters (a mix of full-time and volunteers) from two local agencies Testing: Same as Round 1 Key takeaways The total number of high-range (95th percentile) toxins across all participants decreased 81.4% The total number of high-range mycotoxins (molds) decreased 86.7% The total number of high-range environmental toxins decreased 85.1% The total number of high-range environmental toxins decreased 85.1% According to preliminary data, the total number of high-range PFAS chemicals across all Round 2 participants decreased by 80% (A 2023 article from the Harvard Public School of Health explains that PFAS are known as forever chemicals because they dont break down in the environment or in our bodies . A report from the United States Navy states that there is no recommended medical treatment to reduce PFAS in the body. We hope to shift this narrative.) Case studies from Round 2 Case study #1 Participant started with 16 toxins in the 95th percentile and 17 toxins in the 75th

2), ROS release (Fig

Dies bedeutet, dass Glutathion fr die Kontrolle der krpereigenen Vitamin-D-Biosynthese von wesentlicher Bedeutung ist, und zeigt, dass eine Glutathiontherapie bei der Verringerung des Vitamin-D-Mangels von Nutzen sein kann

Hassinen et al., 2011)

doi: 10.1097/00002826-199619040-00011 160 RomitoJ